Sanofi SA (SNY)
47.98
+0.20
(+0.42%)
USD |
NASDAQ |
Nov 21, 16:00
47.98
0.00 (0.00%)
After-Hours: 20:00
Sanofi Gross Profit Margin (Quarterly): 71.14% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 71.14% |
| June 30, 2024 | 70.04% |
| March 31, 2024 | 69.07% |
| December 31, 2023 | 66.82% |
| September 30, 2023 | 69.75% |
| June 30, 2023 | 69.41% |
| March 31, 2023 | 71.66% |
| December 31, 2022 | 67.41% |
| September 30, 2022 | 70.84% |
| June 30, 2022 | 69.74% |
| March 31, 2022 | 71.35% |
| December 31, 2021 | 66.63% |
| September 30, 2021 | 70.09% |
| June 30, 2021 | 68.40% |
| March 31, 2021 | 69.80% |
| June 30, 2020 | 68.26% |
| March 31, 2020 | 69.25% |
| December 31, 2019 | 65.46% |
| September 30, 2019 | 68.41% |
| June 30, 2019 | 69.19% |
| March 31, 2019 | 69.95% |
| December 31, 2018 | 66.35% |
| September 30, 2018 | 68.88% |
| June 30, 2018 | 67.93% |
| March 31, 2018 | 68.68% |
| Date | Value |
|---|---|
| December 31, 2017 | 65.66% |
| September 30, 2017 | 69.63% |
| June 30, 2017 | 67.70% |
| March 31, 2017 | 68.70% |
| December 31, 2016 | 67.76% |
| September 30, 2016 | 70.13% |
| June 30, 2016 | 69.63% |
| March 31, 2016 | 69.13% |
| December 31, 2015 | 67.83% |
| September 30, 2015 | 69.03% |
| June 30, 2015 | 69.16% |
| March 31, 2015 | 68.78% |
| December 31, 2014 | 68.24% |
| September 30, 2014 | 67.70% |
| June 30, 2014 | 67.98% |
| March 31, 2014 | 68.25% |
| December 31, 2013 | 66.16% |
| September 30, 2013 | 66.29% |
| June 30, 2013 | 66.94% |
| March 31, 2013 | 68.76% |
| December 31, 2012 | 66.89% |
| September 30, 2012 | 68.83% |
| June 30, 2012 | 70.08% |
| March 31, 2012 | 70.66% |
| December 31, 2011 | 69.11% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
65.46%
Minimum
Dec 2019
71.66%
Maximum
Mar 2023
69.17%
Average
69.58%
Median
Gross Profit Margin (Quarterly) Benchmarks
| AstraZeneca PLC | 77.29% |
| GSK PLC | 70.08% |
| Eli Lilly and Co | 81.02% |
| Novavax Inc | 28.27% |
| Regeneron Pharmaceuticals Inc | 86.80% |
Gross Profit Margin (Quarterly) Related Metrics
| Profit Margin (Quarterly) | 19.88% |
| Operating Margin (Quarterly) | 28.88% |